VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Verrica Stockholders and Encourages Investors to Contact the Firm
businesswire.com
news
2022-05-30 00:00:00

May 29, 2022 09:00 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Verrica Pharmaceuticals, Inc. ('Verrica' or the 'Company') (NASDAQ: VRCA) on behalf of Verrica stockholders. Our investigation concerns whether Verrica has violated the federal securities laws and/or engaged in other unlawful business practices.



Click here to participate in the action.

Verrica is a dermatology therapeutics company that develops and commercializes treatments for people with skin diseases in the United States.
